Alliancebernstein L.P. Purchases 25,054 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Alliancebernstein L.P. grew its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 4.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 586,699 shares of the company's stock after purchasing an additional 25,054 shares during the period. Alliancebernstein L.P. owned about 0.34% of Option Care Health worth $13,611,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Wellington Management Group LLP boosted its position in Option Care Health by 84.6% in the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock valued at $425,143,000 after buying an additional 8,400,208 shares in the last quarter. Norges Bank bought a new position in Option Care Health in the 4th quarter valued at $60,219,000. Victory Capital Management Inc. increased its stake in shares of Option Care Health by 31.1% in the fourth quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock valued at $49,310,000 after buying an additional 503,840 shares in the last quarter. Magnetar Financial LLC raised its position in Option Care Health by 23.1% in the 4th quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company's stock worth $54,534,000 after purchasing an additional 441,265 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in shares of Option Care Health by 29.6% during the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock valued at $35,065,000 after acquiring an additional 344,875 shares during the period. Institutional investors and hedge funds own 98.05% of the company's stock.

Remove Ads

Insider Activity

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.64% of the stock is currently owned by insiders.

Option Care Health Stock Up 0.2 %

OPCH traded up $0.06 on Monday, hitting $31.61. 353,280 shares of the company were exchanged, compared to its average volume of 1,772,587. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock's fifty day moving average is $33.24 and its 200-day moving average is $28.58. The company has a market cap of $5.19 billion, a PE ratio of 26.56, a PEG ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the company. Barrington Research increased their price target on Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a research note on Thursday, February 27th. JMP Securities reissued a "market outperform" rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and boosted their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. increased their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $33.00.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.